Structure-Based Design of Novel Potent Nonpeptide Thrombin InhibitorsNorbert Hauel, Wolfgang Wienen, Jean–Marie Stassen et al.|Journal of Medicinal Chemistry|2002Cited by 454
Structural Basis for Inhibition Promiscuity of Dual Specific Thrombin and Factor Xa Blood Coagulation InhibitorsHerbert Nar, Norbert Hauel, Henning Priepke et al.|Structure|2001Cited by 83
Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as novel, potent antithrombotic agentsUwe J. Ries, Herbert Nar, Wolfgang Wienen et al.|Bioorganic & Medicinal Chemistry Letters|2003Cited by 80
The Discovery of Dabigatran EtexilateJoanne van Ryn, Andreas Clemens, Ashley Goss et al.|Frontiers in Pharmacology|2013Cited by 71
3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: A class of potent DPP-4 inhibitorsMatthias Eckhardt, Ralf Lotz, Norbert Hauel et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 40